NCT04387526 is a Phase 2, PHASE3 clinical trial of (SOF and DCV) in Chronic Hepatitis C Virus Infection, sponsored by Beni-Suef University.

Who is sponsoring NCT04387526?

NCT04387526 is sponsored by Beni-Suef University.

What drugs are being tested in NCT04387526?

Interventions in NCT04387526: (SOF and DCV), (SOF, DCV, and RBV).

What condition does NCT04387526 study?

NCT04387526 studies Chronic Hepatitis C Virus Infection.

Is NCT04387526 still recruiting?

NCT04387526 is currently completed. Last updated 15 May 2020.

Last reviewed 2020-05-15 · How we verify

NCT04387526

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sofosbuvir Plus Daclatasvir With or Without Ribavirin and Chronic HCV Genotype (GT) 4

Completed Phase 2, PHASE3 Last updated 15 May 2020

What this trial tests

Phase 2, PHASE3 trial testing (SOF and DCV) in Chronic Hepatitis C Virus Infection in 946 participants. Completed in 31 May 2017.

Timeline

1 April 2016

Primary endpoint
31 May 2017

31 May 2017

Quick facts

Lead sponsor	Beni-Suef University
Phase	Phase 2, PHASE3
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	946
Start date	1 April 2016
Primary completion	31 May 2017
Estimated completion	31 May 2017

Drugs / interventions tested

(SOF and DCV) — full drug profile →
(SOF, DCV, and RBV) — full drug profile →

Conditions studied

Chronic Hepatitis C Virus Infection — all drugs for Chronic Hepatitis C Virus Infection →

Sponsor

Beni-Suef University

Who can join

Adults 18 to 70, any sex, with Chronic Hepatitis C Virus Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the efficacy and safety of DCV plus sofosbuvir (SOF) with or without ribavirin (RBV) for treatment of Egyptian participants infected with HCV GT4.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Beni-Suef University trials

Trials by the same sponsor.

NCT07536347 — Effect of Adding PNF to IMT on Weaning Off MV · NA · not yet recruiting
NCT07494240 — Effects of Changes in Driving Pressure on Intraoperative Pulmonary Dynamic Compliance and PaO₂/FiO₂ Ratio in Laparoscopi · NA · not yet recruiting
NCT07506499 — Cardiac Rehabilitation in Decompensated Heart Failure · NA · recruiting
NCT07482631 — Robotic Glove Training on Hand Function in Unilateral Cerebral Palsy · NA · not yet recruiting
NCT07509736 — Effect of Pulmonary Rehabilitation in Females With Acute Exacerbation of COPD Induced by Biomass Fuel Smoke · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04387526 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Beni-Suef University
Last refreshed: 15 May 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04387526.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing